Lifeist Subsidiary Mikra Cellular Sciences to Launch First Product “CELLF” to Combat Brain Fog and Unlock Healthy Aging, Announces U.S. Patent Application and Pre-Clinical Study

TORONTO, Dec. 06, 2021 (GLOBE NEWSWIRE) — Lifeist Wellness Inc. (“Lifeist” or the “Company”) (TSXV: LFST) (FRANKFURT: M5B) (OTCMKTS: NXTTF), a health-tech company that leverages advancements in science and technology to enable you to find your path to wellness, today announced that its newly launched biosciences and consumer wellness subsidiary, Mikra Cellular Sciences Inc. (“Mikra”), is poised to launch its first product “CELLF”, a novel cellular therapeutic compound targeting systemic fatigue. As part of pre-launch activities of CELLF, Mikra has filed a patent application with the United States Patent and Trademark Office and partnered with InVivo Biosystems, Inc. (“InVivo Biosystems”) for pre-clinical trials to strengthen its patent claim. Read More